Antisecretory Drugs and Gastric Cancer

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1985 Jun 22

PMID 2860944

Citations 15

Authors

M J Langman

Affiliations

Soon will be listed here.

Citing Articles

PPIs and gastric cancer: any causal relationship?.

Crafa P, Franceschi M, Rodriguez-Castro K, Franzoni L, Russo M, Brandimarte G Acta Biomed. 2023; 94(3):e2023096.

PMID: 37326271 PMC: 10308480. DOI: 10.23750/abm.v94i3.14105.

Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Ahn J, Eom C, Jeon C, Park S World J Gastroenterol. 2013; 19(16):2560-8.

PMID: 23674860 PMC: 3646149. DOI: 10.3748/wjg.v19.i16.2560.

Clinical aspects of ECL-cell abnormalities.

Hirschowitz B Yale J Biol Med. 1999; 71(3-4):303-10.

PMID: 10461361 PMC: 2579000.

Safety of acid-suppressing drugs.

Smallwood R, Berlin R, Castagnoli N, Festen H, Hawkey C, Lam S Dig Dis Sci. 1995; 40(2 Suppl):63S-80S.

PMID: 7859585 DOI: 10.1007/BF02214872.

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Clissold S Drugs. 1986; 32(1):15-47.

PMID: 3527658 DOI: 10.2165/00003495-198632010-00002.

References

Keighley M, Youngs D, Poxon V, Morris D, Muscroft T, Burdon D . Intragastric N-nitrosation is unlikely to be responsible for gastric carcinoma developing after operations for duodenal ulcer. Gut. 1984; 25(3):238-45. PMC: 1432290. DOI: 10.1136/gut.25.3.238. View

Carney J, Go V, Fairbanks V, Moore S, Alport E, Nora F . The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med. 1983; 99(6):761-6. DOI: 10.7326/0003-4819-99-6-761. View

Sharma B, Santana I, Wood E, Walt R, Pereira M, Noone P . Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed). 1984; 289(6447):717-9. PMC: 1442819. DOI: 10.1136/bmj.289.6447.717. View

Betton G, Salmon G . Pathology of the forestomach in rats treated for 1 year with a new histamine H2-receptor antagonist, SK&F 93479 trihydrochloride. Scand J Gastroenterol Suppl. 1984; 101:103-8. View

Streett C, Cimprich R, Robertson J . Pathologic findings in the stomachs of rats treated with the H2-receptor antagonist tiotidine. Scand J Gastroenterol Suppl. 1984; 101:109-17. View

Harris A, Greenberg H . Pernicious anemia and the development of carcinoid tumors of the stomach. JAMA. 1978; 239(12):1160-1. View

Larsson L, Rehfeld J, Stockbrugger R, Blohme G, SCHOON I, Lundqvist G . Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin. Am J Pathol. 1978; 93(1):53-68. PMC: 2018343. View

Elder J, Ganguli P, Gillespie I . Cimetidine and gastric cancer. Lancet. 1979; 1(8124):1005-6. DOI: 10.1016/s0140-6736(79)92757-0. View

Hawker P, Muscroft T, Keighley M . Gastric cancer after cimetidine in patient with two negative pre-treatment biopsies. Lancet. 1980; 1(8170):709-10. View

10.

Richardson C, Feldman M, Brater C, Welborn J . Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine. Gastroenterology. 1981; 80(2):301-6. View

11.

Muscroft T, Youngs D, Burdon D, Keighley M . Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet. 1981; 1(8217):408-10. DOI: 10.1016/s0140-6736(81)91791-8. View

12.

Reed P, Smith P, Haines K, House F, Walters C . Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet. 1981; 2(8246):550-2. DOI: 10.1016/s0140-6736(81)90939-9. View

13.

Reed P, Smith P, Haines K, House F, Walters C . Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet. 1981; 2(8246):553-6. DOI: 10.1016/s0140-6736(81)90940-5. View

14.

Lightfoot N, Ahmet Z, Hunt R, Barnard J, BAVIN P, Brimblecombe R . Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment. Lancet. 1982; 1(8281):1091-5. DOI: 10.1016/s0140-6736(82)92277-2. View

15.

Colin-Jones D, Langman M, Lawson D, Vessey M . Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. Br Med J (Clin Res Ed). 1982; 285(6351):1311-3. DOI: 10.1136/bmj.285.6351.1311. View

16.

Stockbrugger R, Cotton P, Eugenides N, Bartholomew B, Hill M, Walters C . Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut. 1982; 23(12):1048-54. PMC: 1419839. DOI: 10.1136/gut.23.12.1048. View

17.

Colin-Jones D, Langman M, Lawson D, Vessey M . Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br Med J (Clin Res Ed). 1983; 286(6379):1713-6. PMC: 1548215. DOI: 10.1136/bmj.286.6379.1713. View

18.

Morgan J, Kaiser C, Johnson W, Doos W, DAYAL Y, Berman L . Gastric carcinoid (gastrinoma) associated with achlorhydria (pernicious anemia). Cancer. 1983; 51(12):2332-40. DOI: 10.1002/1097-0142(19830615)51:12<2332::aid-cncr2820511228>3.0.co;2-i. View

19.

Morris D, Youngs D, Muscroft T, Cooper J, Rojinski C, Burdon D . Mutagenicity in gastric juice. Gut. 1984; 25(7):723-7. PMC: 1432591. DOI: 10.1136/gut.25.7.723. View